Back to VA VANGUARD CAPITAL MANAGEMENT LLC
ESLA2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in ESTRELLA IMMUNOPHARMA INC
Yes. Vanguard Capital Management holds 416,852 shares of ESLA (Estrella Immunopharma), worth $433,526, as of its Q2 2026 13F filing. It increased the position by 34,383 shares (+9.0%) from Q1 2026. Vanguard Capital Management has held ESLA in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$433,526
Current Shares
416,852
Total Value Change
+$28,109
Total Shares Change
+34,383
Quarter-by-Quarter History
Other major holders of ESLA: VANGUARD GROUP INC, WELLS FARGO & COMPANY/MN